On July 26, 2021, Shenzhen Salubris Pharmaceuticals Co., Ltd. announced that it plans to start a share buyback program. Under the program, the company will repurchase up to CNY 100 million to CNY 200 million worth of its shares. The program will be valid for a period of 12 months.